Pliant Therapeutics, Inc.
PLRX
$1.38
-$0.09-6.12%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.62% | -20.98% | -39.23% | -35.59% | -25.05% |
| Total Depreciation and Amortization | -12.67% | -1.29% | 18.75% | 30.40% | 13.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3.06% | -34.42% | 47.59% | 19.52% | 14.98% |
| Change in Net Operating Assets | -189.46% | -1,443.35% | 683.74% | -127.56% | 251.31% |
| Cash from Operations | -61.42% | -89.87% | 10.91% | -82.95% | 0.02% |
| Capital Expenditure | 82.44% | -242.62% | -853.19% | -107.46% | -815.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.66% | 23.01% | -16.93% | 153.42% | 135.07% |
| Cash from Investing | 16.07% | 22.59% | -19.07% | 146.57% | 134.18% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -73.50% | -56.47% | -29.84% | 104.79% | -99.31% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -97.71% | -53.42% | -22.32% | 324.84% | -92.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -59.37% | -219.75% | -128.23% | 28.72% | -25.83% |